Thursday, August 18, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Moscow, Dec 30 (Prensa Latina) The Russian state corporation Rostec reported this Thursday that its new drug COVID-Globulin, against the SARS-CoV-2 coronavirus, successfully passed clinical trials and received a certificate of permanent registration from the Health Ministry.